Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

SHE:300289 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	617.65	574.27	565.02	798.81	928.6	352.53
Trading Asset Securities	281	316.14	290.29	-	-	-
Cash & Short-Term Investments	898.65	890.41	855.32	798.81	928.6	352.53
Cash Growth	14.59%	4.10%	7.07%	-13.98%	163.41%	19.23%
Accounts Receivable	99.76	99.02	149.76	184.48	232.4	237.52
Other Receivables	18.06	19.56	2.4	6.05	5.67	7.87
Receivables	117.83	118.58	152.16	190.52	238.08	245.39
Inventory	83.3	89.45	88.28	97.44	102.48	78.91
Other Current Assets	18.35	8.71	9.93	23.73	9.96	11.27
Total Current Assets	1,118	1,107	1,106	1,111	1,279	688.1
Property, Plant & Equipment	376.99	402.3	427.68	458.68	474.96	575.94
Long-Term Investments	10.92	11.17	23.66	20.9	1.01	0.97
Goodwill	73.53	73.53	144.66	159.54	190.07	210.49
Other Intangible Assets	21.89	25.17	28.74	33.89	37.74	46.01
Long-Term Accounts Receivable	5.37	1.17	-	-	-	-
Long-Term Deferred Tax Assets	45.88	46.93	43.06	35.52	27.95	23.39
Long-Term Deferred Charges	6.58	12.02	17.23	24.56	26.15	8.75
Other Long-Term Assets	149.78	142.99	147.69	156.22	311.41	74.99
Total Assets	1,809	1,822	1,938	2,000	2,348	1,629
Accounts Payable	12.56	19.79	32.87	18.47	36.32	31.92
Accrued Expenses	0.69	8.21	17.56	31.34	25.8	23.5
Short-Term Debt	-	-	-	-	-	39.04
Current Portion of Leases	2.99	4.11	4.29	3.73	3.31	-
Current Income Taxes Payable	6.74	1.04	2.17	2	2.08	1.36
Current Unearned Revenue	13.22	10.27	10.86	7.91	8.2	8.37
Other Current Liabilities	38.18	37.78	38.63	89.57	103.49	58.7
Total Current Liabilities	74.38	81.2	106.38	153.01	179.21	162.88
Long-Term Leases	1.95	0.72	4.65	8.12	9.82	-
Long-Term Unearned Revenue	14.2	14.57	15.5	18.32	19.07	20.25
Long-Term Deferred Tax Liabilities	5.29	6.67	6.45	6.71	3.01	3.49
Other Long-Term Liabilities	0.68	0.68	0.79	33.19	159.19	63.3
Total Liabilities	96.51	103.84	133.77	219.35	370.3	249.92
Common Stock	544.01	544.01	544.01	544.01	544.01	421.05
Additional Paid-In Capital	610.81	610.81	610.81	610.81	651.39	242.74
Retained Earnings	500.14	507.28	587.82	572.48	639.63	617.21
Treasury Stock	-	-	-	-	-	-19.36
Total Common Equity	1,655	1,662	1,743	1,727	1,835	1,262
Minority Interest	57.61	56.48	61.99	53.16	143.08	117.07
Shareholders' Equity	1,713	1,719	1,805	1,780	1,978	1,379
Total Liabilities & Equity	1,809	1,822	1,938	2,000	2,348	1,629
Total Debt	4.94	4.83	8.95	11.84	13.13	39.04
Net Cash (Debt)	893.71	885.58	846.37	786.97	915.47	313.49
Net Cash Growth	14.79%	4.63%	7.55%	-14.04%	192.03%	26.67%
Net Cash Per Share	1.62	1.63	1.56	1.40	2.04	0.74
Filing Date Shares Outstanding	544.01	544.01	544.01	544.01	544.01	417.8
Total Common Shares Outstanding	544.01	544.01	544.01	544.01	544.01	417.8
Working Capital	1,044	1,026	999.3	957.49	1,100	525.22
Book Value Per Share	3.04	3.06	3.20	3.18	3.37	3.02
Tangible Book Value	1,560	1,563	1,569	1,534	1,607	1,005
Tangible Book Value Per Share	2.87	2.87	2.88	2.82	2.95	2.41
Buildings	-	486.27	495.09	488.24	487.72	595.27
Machinery	-	281.56	253.19	245.25	231.03	219.07
Construction In Progress	-	0.58	0.52	6.4	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.